

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.94419835 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.63034778 |
| 3 | neuronal action potential propagation (GO:0019227) | 5.57617070 |
| 4 | postsynaptic membrane organization (GO:0001941) | 5.38461339 |
| 5 | presynaptic membrane assembly (GO:0097105) | 4.93931220 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.88418127 |
| 7 | L-amino acid import (GO:0043092) | 4.83965514 |
| 8 | positive regulation of synapse maturation (GO:0090129) | 4.79570068 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.75942514 |
| 10 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.73560029 |
| 11 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 4.71027826 |
| 12 | synaptic vesicle exocytosis (GO:0016079) | 4.61895328 |
| 13 | synaptic transmission, dopaminergic (GO:0001963) | 4.60922365 |
| 14 | cellular potassium ion homeostasis (GO:0030007) | 4.59988512 |
| 15 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.51225300 |
| 16 | neuromuscular process controlling balance (GO:0050885) | 4.50739142 |
| 17 | glutamate receptor signaling pathway (GO:0007215) | 4.45252496 |
| 18 | adenosine receptor signaling pathway (GO:0001973) | 4.44868646 |
| 19 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.41300147 |
| 20 | regulation of synaptic vesicle transport (GO:1902803) | 4.37679751 |
| 21 | neuronal action potential (GO:0019228) | 4.36614563 |
| 22 | glutamate secretion (GO:0014047) | 4.35248138 |
| 23 | axon ensheathment in central nervous system (GO:0032291) | 4.30165270 |
| 24 | central nervous system myelination (GO:0022010) | 4.30165270 |
| 25 | cAMP catabolic process (GO:0006198) | 4.27549285 |
| 26 | membrane depolarization during action potential (GO:0086010) | 4.26294492 |
| 27 | startle response (GO:0001964) | 4.24594646 |
| 28 | behavioral fear response (GO:0001662) | 4.20007154 |
| 29 | behavioral defense response (GO:0002209) | 4.20007154 |
| 30 | neurotransmitter secretion (GO:0007269) | 4.20007127 |
| 31 | presynaptic membrane organization (GO:0097090) | 4.19834920 |
| 32 | endothelium development (GO:0003158) | 4.14625740 |
| 33 | locomotory exploration behavior (GO:0035641) | 4.13970691 |
| 34 | negative regulation of hormone biosynthetic process (GO:0032353) | 4.04538148 |
| 35 | cyclic nucleotide catabolic process (GO:0009214) | 4.02527632 |
| 36 | sodium ion export (GO:0071436) | 3.90674571 |
| 37 | cerebellar granule cell differentiation (GO:0021707) | 3.85951153 |
| 38 | exploration behavior (GO:0035640) | 3.85667242 |
| 39 | neuromuscular process (GO:0050905) | 3.85407037 |
| 40 | regulation of synapse structural plasticity (GO:0051823) | 3.84579920 |
| 41 | amino acid import (GO:0043090) | 3.84439570 |
| 42 | positive regulation of membrane potential (GO:0045838) | 3.83440098 |
| 43 | respiratory chain complex IV assembly (GO:0008535) | 3.82259393 |
| 44 | positive regulation of dendritic spine development (GO:0060999) | 3.77027090 |
| 45 | regulation of synapse maturation (GO:0090128) | 3.76176298 |
| 46 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.73800998 |
| 47 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.70110274 |
| 48 | positive regulation of neurotransmitter transport (GO:0051590) | 3.69584503 |
| 49 | auditory behavior (GO:0031223) | 3.69296300 |
| 50 | neuronal ion channel clustering (GO:0045161) | 3.69266019 |
| 51 | neurotransmitter transport (GO:0006836) | 3.65043226 |
| 52 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.64113979 |
| 53 | fear response (GO:0042596) | 3.63664815 |
| 54 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.62952642 |
| 55 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.61969247 |
| 56 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.61916112 |
| 57 | response to amphetamine (GO:0001975) | 3.59958436 |
| 58 | regulation of neurotransmitter secretion (GO:0046928) | 3.58920962 |
| 59 | regulation of neurotransmitter transport (GO:0051588) | 3.56485739 |
| 60 | neurotransmitter uptake (GO:0001504) | 3.53908747 |
| 61 | positive regulation of amino acid transport (GO:0051957) | 3.53889479 |
| 62 | short-term memory (GO:0007614) | 3.46974329 |
| 63 | DNA deamination (GO:0045006) | 3.45611769 |
| 64 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.42841187 |
| 65 | vocalization behavior (GO:0071625) | 3.42255044 |
| 66 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.41841491 |
| 67 | protein localization to synapse (GO:0035418) | 3.38060899 |
| 68 | cellular response to ATP (GO:0071318) | 3.37503305 |
| 69 | facial nerve structural organization (GO:0021612) | 3.37452141 |
| 70 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.36508443 |
| 71 | negative regulation of hormone metabolic process (GO:0032351) | 3.35426094 |
| 72 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.33943289 |
| 73 | negative regulation of myotube differentiation (GO:0010832) | 3.30559068 |
| 74 | regulation of synaptic plasticity (GO:0048167) | 3.30106603 |
| 75 | prepulse inhibition (GO:0060134) | 3.29500113 |
| 76 | layer formation in cerebral cortex (GO:0021819) | 3.29035891 |
| 77 | regulation of neurotransmitter levels (GO:0001505) | 3.26817556 |
| 78 | cell communication by electrical coupling (GO:0010644) | 3.26715623 |
| 79 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.26699751 |
| 80 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.26699751 |
| 81 | cell communication involved in cardiac conduction (GO:0086065) | 3.26198791 |
| 82 | membrane depolarization (GO:0051899) | 3.25666032 |
| 83 | behavioral response to cocaine (GO:0048148) | 3.25650539 |
| 84 | cytochrome complex assembly (GO:0017004) | 3.24375347 |
| 85 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.23349879 |
| 86 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.22655662 |
| 87 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.21572569 |
| 88 | action potential (GO:0001508) | 3.21066986 |
| 89 | detection of calcium ion (GO:0005513) | 3.20953426 |
| 90 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.20504057 |
| 91 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.18897449 |
| 92 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.18741835 |
| 93 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.18283974 |
| 94 | potassium ion import (GO:0010107) | 3.16659599 |
| 95 | synaptic vesicle maturation (GO:0016188) | 3.16452641 |
| 96 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.13905154 |
| 97 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.13660044 |
| 98 | serotonin metabolic process (GO:0042428) | 3.12491646 |
| 99 | mechanosensory behavior (GO:0007638) | 3.11713660 |
| 100 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.11011972 |
| 101 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.11011972 |
| 102 | glycosphingolipid biosynthetic process (GO:0006688) | 3.09806243 |
| 103 | astrocyte development (GO:0014002) | 3.09657154 |
| 104 | long-term memory (GO:0007616) | 3.09577216 |
| 105 | long-term synaptic potentiation (GO:0060291) | 3.09476550 |
| 106 | learning (GO:0007612) | 3.08687732 |
| 107 | potassium ion homeostasis (GO:0055075) | 3.07349671 |
| 108 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.07209078 |
| 109 | negative regulation of neurotransmitter transport (GO:0051589) | 3.06618918 |
| 110 | regulation of Rap GTPase activity (GO:0032317) | 3.05661577 |
| 111 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.04815578 |
| 112 | regulation of protein kinase A signaling (GO:0010738) | 3.04057546 |
| 113 | adult walking behavior (GO:0007628) | 3.03951755 |
| 114 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.02096402 |
| 115 | mannosylation (GO:0097502) | 3.02023824 |
| 116 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.01485505 |
| 117 | dopamine receptor signaling pathway (GO:0007212) | 3.00466994 |
| 118 | striatum development (GO:0021756) | 3.00247407 |
| 119 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.99236173 |
| 120 | regulation of norepinephrine secretion (GO:0014061) | 2.99076089 |
| 121 | regulation of pigment cell differentiation (GO:0050932) | 2.96952779 |
| 122 | peristalsis (GO:0030432) | 2.96655591 |
| 123 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.94569476 |
| 124 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.92840211 |
| 125 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.92393957 |
| 126 | cotranslational protein targeting to membrane (GO:0006613) | 2.91431533 |
| 127 | negative regulation of catecholamine secretion (GO:0033604) | 2.91080939 |
| 128 | protein targeting to ER (GO:0045047) | 2.89990494 |
| 129 | myeloid leukocyte mediated immunity (GO:0002444) | 2.88351619 |
| 130 | cerebellar Purkinje cell layer development (GO:0021680) | 2.88209623 |
| 131 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.87592210 |
| 132 | visual learning (GO:0008542) | 2.86917978 |
| 133 | neuron-neuron synaptic transmission (GO:0007270) | 2.85938879 |
| 134 | response to auditory stimulus (GO:0010996) | 2.81577241 |
| 135 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.81256917 |
| 136 | viral transcription (GO:0019083) | 2.81146406 |
| 137 | negative regulation of norepinephrine secretion (GO:0010700) | 2.80867577 |
| 138 | GDP-mannose metabolic process (GO:0019673) | 2.80349304 |
| 139 | cAMP metabolic process (GO:0046058) | 2.78526597 |
| 140 | cranial nerve morphogenesis (GO:0021602) | 2.77483232 |
| 141 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.76787105 |
| 142 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.76133008 |
| 143 | protein localization to endoplasmic reticulum (GO:0070972) | 2.75659560 |
| 144 | signal peptide processing (GO:0006465) | 2.74302637 |
| 145 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.73819194 |
| 146 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.73079278 |
| 147 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.72462292 |
| 148 | regulation of glutamate secretion (GO:0014048) | 2.71870553 |
| 149 | neuron cell-cell adhesion (GO:0007158) | 2.69911856 |
| 150 | regulation of dendritic spine development (GO:0060998) | 2.69383823 |
| 151 | protein heterotetramerization (GO:0051290) | 2.68695187 |
| 152 | dendritic spine morphogenesis (GO:0060997) | 2.67012660 |
| 153 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.66932447 |
| 154 | amino sugar catabolic process (GO:0046348) | 2.66422864 |
| 155 | translational termination (GO:0006415) | 2.64846833 |
| 156 | synaptic transmission, glutamatergic (GO:0035249) | 2.64439606 |
| 157 | regulation of postsynaptic membrane potential (GO:0060078) | 2.64009055 |
| 158 | regulation of respiratory system process (GO:0044065) | 2.63660271 |
| 159 | visual behavior (GO:0007632) | 2.62409429 |
| 160 | regulation of dopamine metabolic process (GO:0042053) | 2.61979983 |
| 161 | regulation of catecholamine metabolic process (GO:0042069) | 2.61979983 |
| 162 | regulation of respiratory gaseous exchange (GO:0043576) | 2.55980887 |
| 163 | cranial nerve structural organization (GO:0021604) | 2.54876025 |
| 164 | regulation of neurotransmitter uptake (GO:0051580) | 2.54799332 |
| 165 | developmental pigmentation (GO:0048066) | 2.53680695 |
| 166 | gamma-aminobutyric acid transport (GO:0015812) | 2.53467256 |
| 167 | transmission of nerve impulse (GO:0019226) | 2.53269710 |
| 168 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.52581737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 8.95244747 |
| 2 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 3.78303034 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.37611797 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.15179130 |
| 5 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.80240379 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.74659989 |
| 7 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.74406496 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.67823017 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.64181545 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.44247011 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.37728449 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.37728449 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.35238185 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.30860737 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.29785315 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.25087240 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.21840318 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.19216853 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.17502962 |
| 20 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.14831727 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.14352456 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.10955316 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.99465570 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.96707551 |
| 25 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.89273731 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.89013407 |
| 27 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.85592769 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.83713672 |
| 29 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.79410830 |
| 30 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.71967904 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.70723914 |
| 32 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.70610474 |
| 33 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.69168384 |
| 34 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67088375 |
| 35 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.66186014 |
| 36 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.65386378 |
| 37 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.60178771 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.59046067 |
| 39 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.58549096 |
| 40 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.58155081 |
| 41 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.57737166 |
| 42 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.57381540 |
| 43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.56529925 |
| 44 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53419011 |
| 45 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52661929 |
| 46 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.49953047 |
| 47 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.48594979 |
| 48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48093541 |
| 49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.46787925 |
| 50 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.44612263 |
| 51 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.44039350 |
| 52 | TCF4_23295773_ChIP-Seq_U87_Human | 1.43203500 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41945781 |
| 54 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.41886309 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.41318602 |
| 56 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.39956916 |
| 57 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.32475549 |
| 58 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32054503 |
| 59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.30027583 |
| 60 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.29313608 |
| 61 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.28700650 |
| 62 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28700650 |
| 63 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.27299553 |
| 64 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.25984980 |
| 65 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.25414212 |
| 66 | AR_19668381_ChIP-Seq_PC3_Human | 1.24483480 |
| 67 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23484035 |
| 68 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22578685 |
| 69 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.22295417 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21070785 |
| 71 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17657754 |
| 72 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.16929247 |
| 73 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16793112 |
| 74 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15528061 |
| 75 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.14942748 |
| 76 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.14244367 |
| 77 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13803303 |
| 78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13639647 |
| 79 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.12485766 |
| 80 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12424005 |
| 81 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12390556 |
| 82 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11921166 |
| 83 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.10863371 |
| 84 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10414737 |
| 85 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.09911449 |
| 86 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09905464 |
| 87 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.09397208 |
| 88 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08321091 |
| 89 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07940647 |
| 90 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07700811 |
| 91 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.06465654 |
| 92 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.03893242 |
| 93 | JUN_21703547_ChIP-Seq_K562_Human | 1.03765161 |
| 94 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.03701468 |
| 95 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02027509 |
| 96 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.01750667 |
| 97 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00354007 |
| 98 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.00281967 |
| 99 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99811464 |
| 100 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99615397 |
| 101 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99528060 |
| 102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99401604 |
| 103 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.99382976 |
| 104 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.99114372 |
| 105 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98811541 |
| 106 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.98155528 |
| 107 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.97286305 |
| 108 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.96920690 |
| 109 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96759210 |
| 110 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96686973 |
| 111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96603885 |
| 112 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.96094580 |
| 113 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.95050765 |
| 114 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.93909409 |
| 115 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93378638 |
| 116 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.93215427 |
| 117 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.93063981 |
| 118 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92819094 |
| 119 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.92250214 |
| 120 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.91518121 |
| 121 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91276733 |
| 122 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.90724144 |
| 123 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90399637 |
| 124 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89694407 |
| 125 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.89435695 |
| 126 | P300_19829295_ChIP-Seq_ESCs_Human | 0.89203120 |
| 127 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.88854402 |
| 128 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.87332217 |
| 129 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.87209323 |
| 130 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.86134605 |
| 131 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.84287103 |
| 132 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.83443717 |
| 133 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.82765571 |
| 134 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.82613282 |
| 135 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.81867506 |
| 136 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.81643369 |
| 137 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.81512891 |
| 138 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81450899 |
| 139 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.81429672 |
| 140 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.81104467 |
| 141 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.80962168 |
| 142 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.79754945 |
| 143 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.79380028 |
| 144 | KDM2B_26808549_Chip-Seq_REH_Human | 0.79202051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 6.12323468 |
| 2 | MP0002822_catalepsy | 4.82634925 |
| 3 | MP0001188_hyperpigmentation | 4.60614711 |
| 4 | MP0005409_darkened_coat_color | 4.33760505 |
| 5 | MP0003880_abnormal_central_pattern | 3.90987306 |
| 6 | MP0003724_increased_susceptibility_to | 3.02986299 |
| 7 | MP0003303_peritoneal_inflammation | 2.87700837 |
| 8 | MP0001986_abnormal_taste_sensitivity | 2.73007980 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 2.67059681 |
| 10 | MP0005174_abnormal_tail_pigmentation | 2.49338415 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.42165836 |
| 12 | MP0000015_abnormal_ear_pigmentation | 2.38981352 |
| 13 | MP0006292_abnormal_olfactory_placode | 2.38665709 |
| 14 | MP0009745_abnormal_behavioral_response | 2.37499849 |
| 15 | MP0003690_abnormal_glial_cell | 2.35887687 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.35114834 |
| 17 | MP0003136_yellow_coat_color | 2.31059737 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.00783445 |
| 19 | MP0005423_abnormal_somatic_nervous | 1.95051146 |
| 20 | MP0004270_analgesia | 1.92656735 |
| 21 | MP0001486_abnormal_startle_reflex | 1.87277892 |
| 22 | MP0002272_abnormal_nervous_system | 1.80217662 |
| 23 | MP0001968_abnormal_touch/_nociception | 1.78776151 |
| 24 | MP0002909_abnormal_adrenal_gland | 1.78645482 |
| 25 | MP0001529_abnormal_vocalization | 1.75413150 |
| 26 | MP0001485_abnormal_pinna_reflex | 1.72042260 |
| 27 | MP0004885_abnormal_endolymph | 1.69953915 |
| 28 | MP0003879_abnormal_hair_cell | 1.68995660 |
| 29 | MP0002063_abnormal_learning/memory/cond | 1.67932902 |
| 30 | MP0002064_seizures | 1.63991019 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 1.63663946 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.59882850 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.57203298 |
| 34 | MP0002734_abnormal_mechanical_nocicepti | 1.56875302 |
| 35 | MP0000372_irregular_coat_pigmentation | 1.56798013 |
| 36 | MP0001970_abnormal_pain_threshold | 1.56585159 |
| 37 | MP0000778_abnormal_nervous_system | 1.56305760 |
| 38 | MP0002095_abnormal_skin_pigmentation | 1.50997558 |
| 39 | MP0003122_maternal_imprinting | 1.49180266 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.41940981 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.41426459 |
| 42 | MP0003631_nervous_system_phenotype | 1.38151962 |
| 43 | MP0009046_muscle_twitch | 1.37430085 |
| 44 | MP0006276_abnormal_autonomic_nervous | 1.35269430 |
| 45 | MP0004381_abnormal_hair_follicle | 1.35108581 |
| 46 | MP0000631_abnormal_neuroendocrine_gland | 1.34135602 |
| 47 | MP0003787_abnormal_imprinting | 1.33307427 |
| 48 | MP0004147_increased_porphyrin_level | 1.31892116 |
| 49 | MP0003646_muscle_fatigue | 1.31294918 |
| 50 | MP0008569_lethality_at_weaning | 1.28844525 |
| 51 | MP0000681_abnormal_thyroid_gland | 1.27665121 |
| 52 | MP0005379_endocrine/exocrine_gland_phen | 1.26207705 |
| 53 | MP0003329_amyloid_beta_deposits | 1.25769236 |
| 54 | MP0008260_abnormal_autophagy | 1.24455877 |
| 55 | MP0001905_abnormal_dopamine_level | 1.24158389 |
| 56 | MP0003634_abnormal_glial_cell | 1.23721911 |
| 57 | MP0004142_abnormal_muscle_tone | 1.21630293 |
| 58 | MP0002067_abnormal_sensory_capabilities | 1.21242898 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.17711955 |
| 60 | MP0008877_abnormal_DNA_methylation | 1.16884424 |
| 61 | MP0002733_abnormal_thermal_nociception | 1.15913069 |
| 62 | MP0001502_abnormal_circadian_rhythm | 1.15232413 |
| 63 | MP0001501_abnormal_sleep_pattern | 1.13856695 |
| 64 | MP0001984_abnormal_olfaction | 1.07882603 |
| 65 | MP0002152_abnormal_brain_morphology | 1.06002246 |
| 66 | MP0002177_abnormal_outer_ear | 1.05974137 |
| 67 | MP0001963_abnormal_hearing_physiology | 1.05555295 |
| 68 | MP0000613_abnormal_salivary_gland | 1.05357533 |
| 69 | MP0009780_abnormal_chondrocyte_physiolo | 1.04836090 |
| 70 | MP0000678_abnormal_parathyroid_gland | 1.03668253 |
| 71 | MP0005645_abnormal_hypothalamus_physiol | 1.02884098 |
| 72 | MP0002751_abnormal_autonomic_nervous | 1.02853237 |
| 73 | MP0003632_abnormal_nervous_system | 1.02683000 |
| 74 | MP0002693_abnormal_pancreas_physiology | 1.02158480 |
| 75 | MP0005595_abnormal_vascular_smooth | 1.00298728 |
| 76 | MP0004510_myositis | 0.99243756 |
| 77 | MP0001944_abnormal_pancreas_morphology | 0.96319551 |
| 78 | MP0002090_abnormal_vision | 0.95034251 |
| 79 | MP0002148_abnormal_hypersensitivity_rea | 0.92376120 |
| 80 | MP0001299_abnormal_eye_distance/ | 0.90346231 |
| 81 | MP0002160_abnormal_reproductive_system | 0.88364171 |
| 82 | MP0002736_abnormal_nociception_after | 0.86193501 |
| 83 | MP0002184_abnormal_innervation | 0.85742921 |
| 84 | MP0005386_behavior/neurological_phenoty | 0.85652843 |
| 85 | MP0004924_abnormal_behavior | 0.85652843 |
| 86 | MP0003866_abnormal_defecation | 0.84683565 |
| 87 | MP0002163_abnormal_gland_morphology | 0.84409672 |
| 88 | MP0002735_abnormal_chemical_nociception | 0.83566663 |
| 89 | MP0003137_abnormal_impulse_conducting | 0.81161160 |
| 90 | MP0008872_abnormal_physiological_respon | 0.80774150 |
| 91 | MP0002877_abnormal_melanocyte_morpholog | 0.80437799 |
| 92 | MP0001919_abnormal_reproductive_system | 0.76846765 |
| 93 | MP0003283_abnormal_digestive_organ | 0.75915866 |
| 94 | MP0000049_abnormal_middle_ear | 0.75905100 |
| 95 | MP0005671_abnormal_response_to | 0.75574153 |
| 96 | MP0000920_abnormal_myelination | 0.75346074 |
| 97 | MP0000955_abnormal_spinal_cord | 0.74336060 |
| 98 | MP0003890_abnormal_embryonic-extraembry | 0.73792806 |
| 99 | MP0003828_pulmonary_edema | 0.73688847 |
| 100 | MP0002066_abnormal_motor_capabilities/c | 0.72614949 |
| 101 | MP0003868_abnormal_feces_composition | 0.72548060 |
| 102 | MP0002882_abnormal_neuron_morphology | 0.72128017 |
| 103 | MP0003121_genomic_imprinting | 0.72039281 |
| 104 | MP0010386_abnormal_urinary_bladder | 0.71286341 |
| 105 | MP0004811_abnormal_neuron_physiology | 0.70940038 |
| 106 | MP0005084_abnormal_gallbladder_morpholo | 0.69755400 |
| 107 | MP0002102_abnormal_ear_morphology | 0.69575467 |
| 108 | MP0001177_atelectasis | 0.68626703 |
| 109 | MP0001664_abnormal_digestion | 0.67547801 |
| 110 | MP0009785_altered_susceptibility_to | 0.67147035 |
| 111 | MP0005000_abnormal_immune_tolerance | 0.66653656 |
| 112 | MP0005394_taste/olfaction_phenotype | 0.66220360 |
| 113 | MP0005499_abnormal_olfactory_system | 0.66220360 |
| 114 | MP0008874_decreased_physiological_sensi | 0.66131373 |
| 115 | MP0001346_abnormal_lacrimal_gland | 0.64651674 |
| 116 | MP0005551_abnormal_eye_electrophysiolog | 0.64107941 |
| 117 | MP0002075_abnormal_coat/hair_pigmentati | 0.63918568 |
| 118 | MP0002229_neurodegeneration | 0.63864605 |
| 119 | MP0003172_abnormal_lysosome_physiology | 0.63450189 |
| 120 | MP0002069_abnormal_eating/drinking_beha | 0.63395594 |
| 121 | MP0004043_abnormal_pH_regulation | 0.63239090 |
| 122 | MP0003123_paternal_imprinting | 0.62932067 |
| 123 | MP0002752_abnormal_somatic_nervous | 0.62864478 |
| 124 | MP0001186_pigmentation_phenotype | 0.62711378 |
| 125 | MP0002933_joint_inflammation | 0.61952646 |
| 126 | MP0010769_abnormal_survival | 0.61365127 |
| 127 | MP0004742_abnormal_vestibular_system | 0.61302063 |
| 128 | MP0010770_preweaning_lethality | 0.60610037 |
| 129 | MP0002082_postnatal_lethality | 0.60610037 |
| 130 | MP0003878_abnormal_ear_physiology | 0.59876282 |
| 131 | MP0005377_hearing/vestibular/ear_phenot | 0.59876282 |
| 132 | MP0005167_abnormal_blood-brain_barrier | 0.58432159 |
| 133 | MP0005171_absent_coat_pigmentation | 0.58166159 |
| 134 | MP0010768_mortality/aging | 0.57657739 |
| 135 | MP0003763_abnormal_thymus_physiology | 0.57235137 |
| 136 | MP0005535_abnormal_body_temperature | 0.57196954 |
| 137 | MP0003633_abnormal_nervous_system | 0.56637384 |
| 138 | MP0002653_abnormal_ependyma_morphology | 0.56411717 |
| 139 | MP0005248_abnormal_Harderian_gland | 0.56258596 |
| 140 | MP0005187_abnormal_penis_morphology | 0.55219144 |
| 141 | MP0009672_abnormal_birth_weight | 0.53452605 |
| 142 | MP0003861_abnormal_nervous_system | 0.50250005 |
| 143 | MP0001943_abnormal_respiration | 0.49520732 |
| 144 | MP0002254_reproductive_system_inflammat | 0.49333804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reduced antithrombin III activity (HP:0001976) | 6.53739592 |
| 2 | Type I transferrin isoform profile (HP:0003642) | 6.26479411 |
| 3 | Focal motor seizures (HP:0011153) | 4.69965624 |
| 4 | Torticollis (HP:0000473) | 4.66533700 |
| 5 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 4.62747053 |
| 6 | Abnormal protein N-linked glycosylation (HP:0012347) | 4.62747053 |
| 7 | Abnormal protein glycosylation (HP:0012346) | 4.62747053 |
| 8 | Abnormal glycosylation (HP:0012345) | 4.62747053 |
| 9 | Epileptic encephalopathy (HP:0200134) | 4.40293043 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 4.37920449 |
| 11 | Annular pancreas (HP:0001734) | 4.09967234 |
| 12 | Hypothermia (HP:0002045) | 4.08055625 |
| 13 | Dialeptic seizures (HP:0011146) | 3.95972255 |
| 14 | Myokymia (HP:0002411) | 3.82790047 |
| 15 | Craniofacial dystonia (HP:0012179) | 3.76490996 |
| 16 | Atonic seizures (HP:0010819) | 3.75940526 |
| 17 | Cortical visual impairment (HP:0100704) | 3.70901903 |
| 18 | Focal dystonia (HP:0004373) | 3.69902300 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 3.66277063 |
| 20 | Truncal ataxia (HP:0002078) | 3.63629252 |
| 21 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.62068704 |
| 22 | Obstructive sleep apnea (HP:0002870) | 3.56010691 |
| 23 | Absence seizures (HP:0002121) | 3.46904407 |
| 24 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.44548390 |
| 25 | Mutism (HP:0002300) | 3.40883058 |
| 26 | Severe visual impairment (HP:0001141) | 3.30153296 |
| 27 | Abnormality of binocular vision (HP:0011514) | 3.25187017 |
| 28 | Diplopia (HP:0000651) | 3.25187017 |
| 29 | Pheochromocytoma (HP:0002666) | 3.23204832 |
| 30 | Neurofibrillary tangles (HP:0002185) | 3.18551672 |
| 31 | Epileptiform EEG discharges (HP:0011182) | 3.15566309 |
| 32 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.12828124 |
| 33 | Ocular albinism (HP:0001107) | 3.08683140 |
| 34 | Progressive cerebellar ataxia (HP:0002073) | 3.08334719 |
| 35 | Nonprogressive disorder (HP:0003680) | 3.05994416 |
| 36 | Abnormality of magnesium homeostasis (HP:0004921) | 3.05993033 |
| 37 | Gaze-evoked nystagmus (HP:0000640) | 3.02570311 |
| 38 | Increased hepatocellular lipid droplets (HP:0006565) | 3.00505056 |
| 39 | Hyperventilation (HP:0002883) | 3.00049872 |
| 40 | Thyroid-stimulating hormone excess (HP:0002925) | 2.93769497 |
| 41 | Renal Fanconi syndrome (HP:0001994) | 2.91262007 |
| 42 | Dysmetria (HP:0001310) | 2.90586966 |
| 43 | EEG with generalized epileptiform discharges (HP:0011198) | 2.89759075 |
| 44 | Poor eye contact (HP:0000817) | 2.89397679 |
| 45 | Hemiparesis (HP:0001269) | 2.88654112 |
| 46 | Postural instability (HP:0002172) | 2.86397272 |
| 47 | Intention tremor (HP:0002080) | 2.81586474 |
| 48 | Iris hypopigmentation (HP:0007730) | 2.78667076 |
| 49 | Hemiplegia (HP:0002301) | 2.73565539 |
| 50 | Exertional dyspnea (HP:0002875) | 2.72771619 |
| 51 | Ankle clonus (HP:0011448) | 2.69986028 |
| 52 | Spastic gait (HP:0002064) | 2.69470220 |
| 53 | Hypsarrhythmia (HP:0002521) | 2.65602226 |
| 54 | Dysdiadochokinesis (HP:0002075) | 2.62809281 |
| 55 | Spastic tetraparesis (HP:0001285) | 2.61718173 |
| 56 | Split foot (HP:0001839) | 2.60251884 |
| 57 | Neuroendocrine neoplasm (HP:0100634) | 2.59146476 |
| 58 | Flat occiput (HP:0005469) | 2.57488637 |
| 59 | Abnormal sex determination (HP:0012244) | 2.56611797 |
| 60 | Sex reversal (HP:0012245) | 2.56611797 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.55248374 |
| 62 | Obstructive lung disease (HP:0006536) | 2.55248374 |
| 63 | Hepatocellular necrosis (HP:0001404) | 2.53558095 |
| 64 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.53278126 |
| 65 | Abnormal social behavior (HP:0012433) | 2.50395209 |
| 66 | Impaired social interactions (HP:0000735) | 2.50395209 |
| 67 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.49126557 |
| 68 | Scanning speech (HP:0002168) | 2.48477654 |
| 69 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.47356296 |
| 70 | Attenuation of retinal blood vessels (HP:0007843) | 2.46762936 |
| 71 | Hepatoblastoma (HP:0002884) | 2.46343108 |
| 72 | Increased circulating renin level (HP:0000848) | 2.45303960 |
| 73 | Stomatitis (HP:0010280) | 2.44952490 |
| 74 | Agitation (HP:0000713) | 2.44291551 |
| 75 | Late onset (HP:0003584) | 2.44133131 |
| 76 | True hermaphroditism (HP:0010459) | 2.42490107 |
| 77 | Cerebral inclusion bodies (HP:0100314) | 2.40468916 |
| 78 | Sleep apnea (HP:0010535) | 2.39669218 |
| 79 | Spinal canal stenosis (HP:0003416) | 2.36146841 |
| 80 | Heart block (HP:0012722) | 2.35597612 |
| 81 | Testicular atrophy (HP:0000029) | 2.35205229 |
| 82 | Anxiety (HP:0000739) | 2.34866666 |
| 83 | Focal seizures (HP:0007359) | 2.34759493 |
| 84 | Bradykinesia (HP:0002067) | 2.33658913 |
| 85 | Lipid accumulation in hepatocytes (HP:0006561) | 2.33532137 |
| 86 | Prolonged QT interval (HP:0001657) | 2.31413670 |
| 87 | Abnormal number of erythroid precursors (HP:0012131) | 2.30743219 |
| 88 | Peripheral hypomyelination (HP:0007182) | 2.29281457 |
| 89 | Abnormality of the corticospinal tract (HP:0002492) | 2.28194117 |
| 90 | Drooling (HP:0002307) | 2.27832858 |
| 91 | Inability to walk (HP:0002540) | 2.27376627 |
| 92 | Status epilepticus (HP:0002133) | 2.26394366 |
| 93 | Akinesia (HP:0002304) | 2.24577698 |
| 94 | Papilledema (HP:0001085) | 2.19970563 |
| 95 | Polyphagia (HP:0002591) | 2.17723211 |
| 96 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.17692550 |
| 97 | Abnormality of the axillary hair (HP:0100134) | 2.17624769 |
| 98 | Abnormality of secondary sexual hair (HP:0009888) | 2.17624769 |
| 99 | Lower limb hyperreflexia (HP:0002395) | 2.17111999 |
| 100 | Horizontal nystagmus (HP:0000666) | 2.16900670 |
| 101 | Inappropriate behavior (HP:0000719) | 2.16001781 |
| 102 | Concave nail (HP:0001598) | 2.15557240 |
| 103 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.15366725 |
| 104 | Abnormality of dental color (HP:0011073) | 2.15317205 |
| 105 | Increased intramyocellular lipid droplets (HP:0012240) | 2.13762921 |
| 106 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.12572786 |
| 107 | Abnormal eating behavior (HP:0100738) | 2.12082116 |
| 108 | Stereotypic behavior (HP:0000733) | 2.11414606 |
| 109 | Bronchomalacia (HP:0002780) | 2.11256209 |
| 110 | Abnormality of cochlea (HP:0000375) | 2.08596475 |
| 111 | Bundle branch block (HP:0011710) | 2.08394326 |
| 112 | Excessive salivation (HP:0003781) | 2.07721644 |
| 113 | Amblyopia (HP:0000646) | 2.06316748 |
| 114 | Limb dystonia (HP:0002451) | 2.06027261 |
| 115 | Atrioventricular block (HP:0001678) | 2.04962059 |
| 116 | Hypomagnesemia (HP:0002917) | 2.04314715 |
| 117 | Spastic tetraplegia (HP:0002510) | 2.04298473 |
| 118 | Abnormal atrioventricular conduction (HP:0005150) | 2.03172412 |
| 119 | Thoracic kyphosis (HP:0002942) | 2.00887286 |
| 120 | Postural tremor (HP:0002174) | 2.00869897 |
| 121 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.00026153 |
| 122 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.00026153 |
| 123 | Depression (HP:0000716) | 1.99016244 |
| 124 | Papillary thyroid carcinoma (HP:0002895) | 1.97767827 |
| 125 | Visual hallucinations (HP:0002367) | 1.97309529 |
| 126 | Protruding tongue (HP:0010808) | 1.96535636 |
| 127 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.96088803 |
| 128 | Lower limb muscle weakness (HP:0007340) | 1.96077509 |
| 129 | Febrile seizures (HP:0002373) | 1.95644768 |
| 130 | Impaired smooth pursuit (HP:0007772) | 1.94646784 |
| 131 | Hepatic necrosis (HP:0002605) | 1.94599574 |
| 132 | Hypoglycemic seizures (HP:0002173) | 1.94097454 |
| 133 | Dry hair (HP:0011359) | 1.93714652 |
| 134 | Abnormality of renal resorption (HP:0011038) | 1.93649542 |
| 135 | Astrocytoma (HP:0009592) | 1.92829502 |
| 136 | Abnormality of the astrocytes (HP:0100707) | 1.92829502 |
| 137 | Reticulocytopenia (HP:0001896) | 1.91586037 |
| 138 | Urinary urgency (HP:0000012) | 1.90981659 |
| 139 | Limb ataxia (HP:0002070) | 1.90606820 |
| 140 | Broad-based gait (HP:0002136) | 1.90442216 |
| 141 | Apathy (HP:0000741) | 1.90282298 |
| 142 | Progressive inability to walk (HP:0002505) | 1.89989372 |
| 143 | Aqueductal stenosis (HP:0002410) | 1.89780907 |
| 144 | Acute lymphatic leukemia (HP:0006721) | 1.89607583 |
| 145 | Congenital sensorineural hearing impairment (HP:0008527) | 1.89225703 |
| 146 | Hyperparathyroidism (HP:0000843) | 1.89109484 |
| 147 | Hyperphosphaturia (HP:0003109) | 1.88658686 |
| 148 | Rapidly progressive (HP:0003678) | 1.87942855 |
| 149 | Absent speech (HP:0001344) | 1.87669851 |
| 150 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.87637489 |
| 151 | Aplasia of the phalanges of the hand (HP:0009802) | 1.87637489 |
| 152 | Aplasia involving bones of the extremities (HP:0009825) | 1.87637489 |
| 153 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.86256237 |
| 154 | Microvesicular hepatic steatosis (HP:0001414) | 1.86026391 |
| 155 | Neuronal loss in central nervous system (HP:0002529) | 1.85631318 |
| 156 | Incomplete penetrance (HP:0003829) | 1.85582794 |
| 157 | Intellectual disability, profound (HP:0002187) | 1.85513321 |
| 158 | Morphological abnormality of the inner ear (HP:0011390) | 1.85390852 |
| 159 | Pancreatic fibrosis (HP:0100732) | 1.84411222 |
| 160 | Muscular hypotonia of the trunk (HP:0008936) | 1.84334085 |
| 161 | Meningitis (HP:0001287) | 1.84010673 |
| 162 | Turricephaly (HP:0000262) | 1.83869177 |
| 163 | Abnormal pupillary function (HP:0007686) | 1.81874520 |
| 164 | Macrocytic anemia (HP:0001972) | 1.81535077 |
| 165 | Aplastic anemia (HP:0001915) | 1.81047511 |
| 166 | Mitral regurgitation (HP:0001653) | 1.80158165 |
| 167 | Progressive muscle weakness (HP:0003323) | 1.80030751 |
| 168 | Mitochondrial inheritance (HP:0001427) | 1.79805725 |
| 169 | Microcytic anemia (HP:0001935) | 1.79708795 |
| 170 | Progressive external ophthalmoplegia (HP:0000590) | 1.79662766 |
| 171 | Bradycardia (HP:0001662) | 1.79547494 |
| 172 | Unilateral renal agenesis (HP:0000122) | 1.77628328 |
| 173 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.76925443 |
| 174 | Type 2 muscle fiber atrophy (HP:0003554) | 1.76434061 |
| 175 | 3-Methylglutaconic aciduria (HP:0003535) | 1.75502414 |
| 176 | Pancreatic cysts (HP:0001737) | 1.75139610 |
| 177 | Hyperphosphatemia (HP:0002905) | 1.74846274 |
| 178 | Decreased central vision (HP:0007663) | 1.74821126 |
| 179 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.73739587 |
| 180 | Action tremor (HP:0002345) | 1.68115795 |
| 181 | Hypoplasia of the fovea (HP:0007750) | 1.64254395 |
| 182 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.64254395 |
| 183 | Muscle fiber atrophy (HP:0100295) | 1.64104105 |
| 184 | Abnormality of the columella (HP:0009929) | 1.63881080 |
| 185 | Capillary hemangiomas (HP:0005306) | 1.61781764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 6.13970742 |
| 2 | FES | 4.55859617 |
| 3 | EIF2AK3 | 4.51026794 |
| 4 | CAMKK2 | 3.51507175 |
| 5 | EPHA4 | 3.44493255 |
| 6 | MUSK | 3.23179720 |
| 7 | MAP3K9 | 3.22168663 |
| 8 | MKNK2 | 3.08191621 |
| 9 | RIPK1 | 2.42803326 |
| 10 | CASK | 2.31133013 |
| 11 | STK16 | 2.29517877 |
| 12 | CAMK1D | 2.22462958 |
| 13 | NLK | 2.15848539 |
| 14 | MAP2K7 | 2.13636869 |
| 15 | CAMK1G | 2.09529589 |
| 16 | NTRK3 | 1.90814236 |
| 17 | TLK1 | 1.87861137 |
| 18 | PNCK | 1.85984622 |
| 19 | PRPF4B | 1.84684743 |
| 20 | IRAK3 | 1.82896591 |
| 21 | NME2 | 1.80433009 |
| 22 | RIPK4 | 1.79842303 |
| 23 | IRAK4 | 1.75063409 |
| 24 | CAMKK1 | 1.62621672 |
| 25 | MKNK1 | 1.57385523 |
| 26 | CDK19 | 1.47792902 |
| 27 | CAMK1 | 1.46011330 |
| 28 | PAK6 | 1.44258353 |
| 29 | TEC | 1.44018839 |
| 30 | EIF2AK2 | 1.41805235 |
| 31 | MAP3K12 | 1.33864959 |
| 32 | PRKD2 | 1.33791367 |
| 33 | ACVR1B | 1.32302883 |
| 34 | FER | 1.32040279 |
| 35 | MAP3K4 | 1.29098024 |
| 36 | FGFR2 | 1.25898993 |
| 37 | MAPK13 | 1.25470858 |
| 38 | IRAK2 | 1.22227348 |
| 39 | SGK1 | 1.15833693 |
| 40 | SGK494 | 1.15635005 |
| 41 | SGK223 | 1.15635005 |
| 42 | SGK2 | 1.15503597 |
| 43 | HIPK2 | 1.13723996 |
| 44 | UHMK1 | 1.13623884 |
| 45 | LATS2 | 1.12750659 |
| 46 | OXSR1 | 1.09228006 |
| 47 | PIM2 | 1.09157399 |
| 48 | PHKG2 | 1.08315215 |
| 49 | PHKG1 | 1.08315215 |
| 50 | MINK1 | 1.07453887 |
| 51 | PINK1 | 1.03549248 |
| 52 | BMPR2 | 1.01538344 |
| 53 | BLK | 0.99781997 |
| 54 | CLK1 | 0.93555667 |
| 55 | TYRO3 | 0.93058896 |
| 56 | IRAK1 | 0.91636203 |
| 57 | ALK | 0.90833864 |
| 58 | MAP3K1 | 0.88144052 |
| 59 | TSSK6 | 0.85112138 |
| 60 | PRKD3 | 0.83045167 |
| 61 | KSR2 | 0.79797854 |
| 62 | PIK3CG | 0.76545555 |
| 63 | ADRBK2 | 0.76227202 |
| 64 | WNK3 | 0.75584076 |
| 65 | SIK2 | 0.74442213 |
| 66 | EIF2AK1 | 0.69920134 |
| 67 | STK39 | 0.69433726 |
| 68 | RPS6KA3 | 0.68867242 |
| 69 | CAMK2B | 0.68327661 |
| 70 | CSK | 0.66183676 |
| 71 | FRK | 0.65947845 |
| 72 | MAP2K4 | 0.65715496 |
| 73 | DAPK2 | 0.64240224 |
| 74 | VRK1 | 0.62913549 |
| 75 | YES1 | 0.62134233 |
| 76 | PLK2 | 0.61536083 |
| 77 | SGK3 | 0.58745798 |
| 78 | LYN | 0.57066413 |
| 79 | MAPK10 | 0.56839423 |
| 80 | CDK5 | 0.56660258 |
| 81 | DYRK2 | 0.56635630 |
| 82 | CAMK2G | 0.56135567 |
| 83 | IKBKE | 0.54815542 |
| 84 | LMTK2 | 0.54663300 |
| 85 | HCK | 0.54266573 |
| 86 | ARAF | 0.52738449 |
| 87 | MARK2 | 0.52459735 |
| 88 | INSRR | 0.52404685 |
| 89 | MAPKAPK5 | 0.51931305 |
| 90 | CAMK4 | 0.50924930 |
| 91 | CDK15 | 0.50489706 |
| 92 | NEK6 | 0.49803538 |
| 93 | PRKCH | 0.49284301 |
| 94 | STK11 | 0.49209626 |
| 95 | PRKG1 | 0.49120581 |
| 96 | SRPK1 | 0.48713900 |
| 97 | CAMK2A | 0.48649053 |
| 98 | CAMK2D | 0.47981663 |
| 99 | CDK18 | 0.46300678 |
| 100 | NTRK1 | 0.46215836 |
| 101 | TNK2 | 0.46046310 |
| 102 | BTK | 0.45356142 |
| 103 | SYK | 0.45053118 |
| 104 | CSNK1E | 0.44860331 |
| 105 | ROCK2 | 0.44674834 |
| 106 | DAPK1 | 0.44412785 |
| 107 | MAPK4 | 0.41285546 |
| 108 | GRK5 | 0.40829334 |
| 109 | MARK1 | 0.40750599 |
| 110 | PRKCB | 0.40568552 |
| 111 | ADRBK1 | 0.39642845 |
| 112 | CDK14 | 0.39576595 |
| 113 | CSNK1A1 | 0.39565909 |
| 114 | CSNK1G3 | 0.39488146 |
| 115 | TXK | 0.39224699 |
| 116 | KIT | 0.37893719 |
| 117 | CSNK1A1L | 0.36559686 |
| 118 | CDK8 | 0.36202940 |
| 119 | MAPK15 | 0.36123867 |
| 120 | MAP3K13 | 0.35743220 |
| 121 | CSNK1D | 0.35436175 |
| 122 | NTRK2 | 0.33570555 |
| 123 | WNK1 | 0.33432205 |
| 124 | PRKG2 | 0.32678560 |
| 125 | BRD4 | 0.32316726 |
| 126 | PRKDC | 0.32166105 |
| 127 | LCK | 0.30908448 |
| 128 | GSK3B | 0.30850376 |
| 129 | BMPR1B | 0.30695710 |
| 130 | WEE1 | 0.30322404 |
| 131 | CDK3 | 0.30194154 |
| 132 | PRKACB | 0.29564796 |
| 133 | RET | 0.29471280 |
| 134 | MAP3K5 | 0.29455825 |
| 135 | PRKCZ | 0.29410175 |
| 136 | TAOK1 | 0.29246288 |
| 137 | BUB1 | 0.28459730 |
| 138 | DYRK1A | 0.28214167 |
| 139 | PRKCG | 0.28213051 |
| 140 | TAOK3 | 0.27964977 |
| 141 | IKBKB | 0.26979778 |
| 142 | PRKCA | 0.26797025 |
| 143 | PRKACA | 0.26640455 |
| 144 | FYN | 0.26065411 |
| 145 | CSNK1G1 | 0.25583895 |
| 146 | MAP3K2 | 0.25565863 |
| 147 | CSNK1G2 | 0.25532272 |
| 148 | ABL2 | 0.25508517 |
| 149 | STK38 | 0.25170459 |
| 150 | PRKCE | 0.23697577 |
| 151 | CDK11A | 0.23474424 |
| 152 | FLT3 | 0.23381138 |
| 153 | GRK7 | 0.22900114 |
| 154 | DAPK3 | 0.22538328 |
| 155 | ZAK | 0.22290828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.36734534 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.98677026 |
| 3 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.96950542 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.70590263 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.68122264 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.42062179 |
| 7 | Cocaine addiction_Homo sapiens_hsa05030 | 2.16311961 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.11310925 |
| 9 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.10875747 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.10386807 |
| 11 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.94311897 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.90435866 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.89214821 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 1.87506313 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.85045557 |
| 16 | Phototransduction_Homo sapiens_hsa04744 | 1.84191198 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.78482209 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.69332636 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.67377444 |
| 20 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.66260496 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.63764975 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.59448878 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.58428724 |
| 24 | DNA replication_Homo sapiens_hsa03030 | 1.55554385 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.53766685 |
| 26 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.46955743 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.46880491 |
| 28 | Thyroid cancer_Homo sapiens_hsa05216 | 1.37378750 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35736463 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33408749 |
| 31 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.32781594 |
| 32 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.31562828 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30541309 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.28232577 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28183063 |
| 36 | Homologous recombination_Homo sapiens_hsa03440 | 1.24360835 |
| 37 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.20227103 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 1.15743157 |
| 39 | Alcoholism_Homo sapiens_hsa05034 | 1.10455237 |
| 40 | Salivary secretion_Homo sapiens_hsa04970 | 1.09087495 |
| 41 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.07574154 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.07161168 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.06463743 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04902239 |
| 45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.03918360 |
| 46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.98420763 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.97996786 |
| 48 | Purine metabolism_Homo sapiens_hsa00230 | 0.95813692 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 0.94311844 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93896654 |
| 51 | Parkinsons disease_Homo sapiens_hsa05012 | 0.88427423 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86198796 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.85623133 |
| 54 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.85477625 |
| 55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.84272924 |
| 56 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83870564 |
| 57 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.82032684 |
| 58 | Circadian rhythm_Homo sapiens_hsa04710 | 0.81506745 |
| 59 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.78422244 |
| 60 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.77645611 |
| 61 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.77387626 |
| 62 | Basal transcription factors_Homo sapiens_hsa03022 | 0.74245606 |
| 63 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74158321 |
| 64 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.72626784 |
| 65 | Glioma_Homo sapiens_hsa05214 | 0.71095328 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 0.70921621 |
| 67 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70829711 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70777879 |
| 69 | Melanogenesis_Homo sapiens_hsa04916 | 0.69354653 |
| 70 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67564184 |
| 71 | Tight junction_Homo sapiens_hsa04530 | 0.66164800 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64650797 |
| 73 | Alzheimers disease_Homo sapiens_hsa05010 | 0.64072495 |
| 74 | RNA polymerase_Homo sapiens_hsa03020 | 0.63828387 |
| 75 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.62239184 |
| 76 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61919327 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61287619 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59776520 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59180917 |
| 80 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58505416 |
| 81 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.57125886 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56780881 |
| 83 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.56657088 |
| 84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55581322 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55561062 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54962359 |
| 87 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.53674240 |
| 88 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.53470952 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53306788 |
| 90 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52135624 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51958127 |
| 92 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.51910644 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.51534020 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50997928 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50230121 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48886538 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48703830 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48240281 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47392713 |
| 100 | Base excision repair_Homo sapiens_hsa03410 | 0.46564449 |
| 101 | Asthma_Homo sapiens_hsa05310 | 0.46127060 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.45457640 |
| 103 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.45170658 |
| 104 | Malaria_Homo sapiens_hsa05144 | 0.44645757 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44619030 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44241803 |
| 107 | Axon guidance_Homo sapiens_hsa04360 | 0.43799181 |
| 108 | Mismatch repair_Homo sapiens_hsa03430 | 0.43776903 |
| 109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42384397 |
| 110 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.39642777 |
| 111 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39607532 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39524158 |
| 113 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38863852 |
| 114 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38685292 |
| 115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38403631 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38074833 |
| 117 | Allograft rejection_Homo sapiens_hsa05330 | 0.37667999 |
| 118 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.37364909 |
| 119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36914406 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.36896181 |
| 121 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.36477565 |
| 122 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.36129276 |
| 123 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.36063867 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35697710 |
| 125 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35661675 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34781547 |
| 127 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.34557258 |
| 128 | Histidine metabolism_Homo sapiens_hsa00340 | 0.34338520 |
| 129 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.34023994 |
| 130 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33673451 |
| 131 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.33462355 |
| 132 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.32514990 |
| 133 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.31295366 |
| 134 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.27380488 |
| 135 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27233992 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.25766892 |
| 137 | Mineral absorption_Homo sapiens_hsa04978 | 0.22241463 |
| 138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.19394725 |
| 139 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.18609339 |
| 140 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.18352356 |
| 141 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.18324233 |
| 142 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.17101573 |
| 143 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.16270663 |
| 144 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.14338007 |

